BioCentury
ARTICLE | Company News

Genvax Ltd., Medical Marketing deal

September 6, 2004 7:00 AM UTC

MMG spun out Genvax, which will develop a technology that involves fusing portions of tetanus toxin with cancer proteins in order to stimulate an immune response. Genvax has three DNA-based vaccines i...